Skip to content

Lucas Nivon

Chief Executive Officer at Cyrus Biotechnology.

Earliest Form D on file: May 2026

Filed May 8, 2026Amendment

Cyrus Biotechnology

Computational protein design for drug discovery

Biotech, Seattle WA

Signed as Chief Executive Officer

$1.5M

sold of $3M offered

Form D

LinkedIn

Reported on an amendment to an earlier filing.

Network

At Cyrus Biotechnology

6 people